Discovery of a Potent and Orally Bioavailable Benzolactam-Derived Inhibitor of Polo-Like Kinase 1 (MLN0905).
Duffey, M.O., Vos, T.J., Adams, R., Alley, J., Anthony, J., Barrett, C., Bharathan, I., Bowman, D., Bump, N.J., Chau, R., Cullis, C., Driscoll, D.L., Elder, A., Forsyth, N., Frazer, J., Guo, J., Guo, L., Hyer, M.L., Janowick, D., Kulkarni, B., Lai, S.J., Lasky, K., Li, G., Li, J., Liao, D., Little, J., Peng, B., Qian, M.G., Reynolds, D.J., Rezaei, M., Scott, M.P., Sells, T.B., Shinde, V., Shi, Q.J., Sintchak, M.D., Soucy, F., Sprott, K.T., Stroud, S.G., Nestor, M., Visiers, I., Weatherhead, G., Ye, Y., D'Amore, N.
J.Med.Chem.